Microbiome Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-2305 | Report Format : | Status : Upcoming |

Abstract

Microbiome Therapeutics Market: Overview

The microbiome is a term that is used for the collection of microbes. In the microbiome therapeutics, prebiotics, probiotics, and synbiotics have an influential role in the prevention, diagnosis, and treatment of different types of disease conditions. The factor that favors the microbiome therapeutics is that unlike the drug molecules microbiome therapeutics do not have any side effects since microbiome are already present in the body.

Microbiome Therapeutics Market: Facts

The scientists are making rapid advancements in the study that involves the widespread network of the microbiome and its effect on the human neurology, skin, metabolism, and the immune system. There is evidence that proves that the presence of the dysbiosis in the gut have an effect on an array of conditions such as atopy, cancer, type 2 diabetes, neurological disorders, inflammatory bowel disease, asthma, obesity, and fatty liver disease. The Bristol Myers-Squibb and Enterome entered into the partnership for the development and the discovery of the biomarkers and the microbiome-derived drug targets which will prove useful in the cancer therapeutics.

Microbiome Therapeutics Market: Segmentation

The global market for the microbiome therapeutics is fragmented into its product type, distribution channel, and the application area. On the basis of the product type, the global market is segregated into prebiotics, probiotics, and synbiotics. On the basis of the distribution channel, the market is categorized into drug stores, super and hypermarkets, hospital pharmacies, retail pharmacies, and e-commerce stores. On the basis of the application area, the market is divided into respiratory health, immune conditions, digestive health, oral health, and others.

Microbiome Therapeutics Market: Growth Factors

The primary factors that are driving the microbiome therapeutics market are increase in the problems related to digestion and rise in the drug-related side effects. The therapy can also be used as a treatment for the disease conditions that have no other treatments, as a dietary supplement for improving the overall health, and it is considered as a non-immunogenic as well. The challenges that the market is facing include the high cost of the therapy due to the fact that this therapy is a complex process and needs the extraction of the bacteria in the laboratory. To add on, other factors that restrict the market growth are lack of proper regulations and the microbiomes are heat sensitive.

Microbiome Therapeutics Market: Regional Analysis

The region that is leading in the microbiome therapeutics market is North America which is followed by European regions. The factor that is favoring the growth of the market in the North America is the growing consumption of the dietary supplements. Factor that favors the growth of the market in Europe is the implementation of the less stringent regulations for marketing the probiotic products. In Asia Pacific region, the microbiome therapeutics market is developing at a good pace.

Microbiome Therapeutics Market: Competitive Players

The key market players that are involved in the microbiome therapeutics market include AB-Biotics, AbbVie Inc., Yakult, Ganeden, Pfizer Inc., Johnson and Johnson, Vedanta Biosciences, Dannon, Bayer, Sigma-Tau Pharmaceuticals, and others.

Microbiome Therapeutics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Immuno-oncology Therapy Market by Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors (PD-1/PD-L1 and CTLA-4), Immune System Modulators, and Cancer Vaccines) and by Therapeutic Areas, for Hospitals, Clinics, ASC’s and Cancer Research Institutes: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Jan-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2534 | Report Format:

The report covers forecast and analysis for the immuno-oncology therapy market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the immuno-oncology therapy mar...Read More

Compounding Pharmacies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2525 | Report Format:

Global Compounding Pharmacies Market: Overview Compounding is the knowledge of preparing and combining tailored medicines for users. These medicines are made on the basis of the prescription from the practitioner wherein, the separate ingredients are blended together according to the recommended...Read More

Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2514 | Report Format:

The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the imp...Read More

Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine and Combined Drug), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2513 | Report Format:

The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along ...Read More

Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2512 | Report Format:

The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive p...Read More

Choose License Type:
Latest Published Reports

View All Published Reports